Papatheodoridi M. Rates and predictors of HBsAg loss after discontinuation of effective long-term Entecavir or Tenofovir therapy in non-cirrhotic HBeAg-negative Chronic Hepatitis B patients: Results from the DARING-B prospective Greek study. PS-159.
Effectiviteit en immunogeniciteit van het R21/Matrix-M-vaccin: 2 jaar follow-up
feb 2023 | Parasitaire infecties